|
CA672478A
(en)
|
|
1963-10-15 |
Heim Roger |
Psilocybin and psilocin
|
|
LU36879A1
(de)
|
1958-02-21 |
|
|
|
|
GB911946A
(en)
|
1958-02-21 |
1962-12-05 |
Sandoz Ltd |
Psilocybin and psilocin and processes for their preparation
|
|
US3075992A
(en)
|
1958-09-12 |
1963-01-29 |
Sandoz Ltd |
Esters of indoles
|
|
NL121067C
(de)
|
1958-09-12 |
|
|
|
|
US3192111A
(en)
|
1959-02-16 |
1965-06-29 |
Sandoz Ltd |
Method of inducing therapeutic tranquilization with psilocybin and psilocin
|
|
IE24138L
(en)
|
1959-02-18 |
1959-08-21 |
Sandoz Ag |
Psilocybin and psilocin
|
|
JPS5576859A
(en)
|
1978-12-01 |
1980-06-10 |
Fujimoto Seiyaku Kk |
Novel preparation of 4-hydroxyindole
|
|
JPS5728046A
(en)
|
1980-07-28 |
1982-02-15 |
Nissan Chem Ind Ltd |
Preparation of 4-substituted indole
|
|
US4499096A
(en)
|
1983-11-18 |
1985-02-12 |
Lotsof Howard S |
Rapid method for interrupting the narcotic addiction syndrome
|
|
EP0152379A3
(de)
|
1984-02-15 |
1986-10-29 |
Ciba-Geigy Ag |
Verfahren zur Herstellung von pharmazeutischen Zusammensetzungen enthaltend unilamellare Liposomen
|
|
US4721612A
(en)
|
1984-04-12 |
1988-01-26 |
The Liposome Company, Inc. |
Steroidal liposomes
|
|
IL76591A0
(en)
|
1984-10-05 |
1986-02-28 |
Bioferon Biochem Substanz |
Pharmaceutical compositions containing ifn-ypsilon and processes for the preparation thereof
|
|
US5785989A
(en)
|
1985-05-01 |
1998-07-28 |
University Utah Research Foundation |
Compositions and methods of manufacturing of oral dissolvable medicaments
|
|
US4587243A
(en)
|
1985-07-15 |
1986-05-06 |
Lotsof Howard S |
Rapid method for interrupting the cocaine and amphetamine abuse syndrome
|
|
DE3689927T3
(de)
|
1985-10-04 |
1998-10-22 |
South African Inventions |
Reagens und Verfahren.
|
|
US5725871A
(en)
|
1989-08-18 |
1998-03-10 |
Danbiosyst Uk Limited |
Drug delivery compositions comprising lysophosphoglycerolipid
|
|
DE68928415T2
(de)
|
1989-09-05 |
1998-02-26 |
Univ Utah Research Inst |
Verfahren und zusammensetzungen zur verabreichung von lipophilen heilmitteln in einer dosierung nach der gewünschten wirkung
|
|
US5629307A
(en)
|
1989-10-20 |
1997-05-13 |
Olney; John W. |
Use of ibogaine in reducing excitotoxic brain damage
|
|
US5935925A
(en)
|
1990-05-08 |
1999-08-10 |
Synaptic Pharmaceutical Corporation |
Methods of treating migraine and compounds useful for such methods
|
|
US5626863A
(en)
|
1992-02-28 |
1997-05-06 |
Board Of Regents, The University Of Texas System |
Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers
|
|
DE69133205T2
(de)
|
1990-10-19 |
2003-12-11 |
New York University, New York |
Eine methode zur transplantation von zellen in das gehirn und ihre therapeutische verwendung
|
|
US5827819A
(en)
|
1990-11-01 |
1998-10-27 |
Oregon Health Sciences University |
Covalent polar lipid conjugates with neurologically active compounds for targeting
|
|
FR2675504B1
(fr)
|
1991-04-16 |
1995-01-27 |
Delalande Sa |
Derives d'aryl-3 oxazolidinone, leur procede de preparation et leur application en therapeutique.
|
|
US5468486A
(en)
|
1992-01-21 |
1995-11-21 |
The University Of Tennessee Research Corporation |
Vaccine containing a protein alkaloid conjugate for the treatment of fescue toxicosis
|
|
US5482706A
(en)
|
1992-04-17 |
1996-01-09 |
Takeda Chemical Industries, Ltd. |
Transmucosal therapeutic composition
|
|
US5871710A
(en)
|
1992-09-04 |
1999-02-16 |
The General Hospital Corporation |
Graft co-polymer adducts of platinum (II) compounds
|
|
US5573776A
(en)
|
1992-12-02 |
1996-11-12 |
Alza Corporation |
Oral osmotic device with hydrogel driving member
|
|
PT628042E
(pt)
|
1992-12-24 |
2002-01-30 |
Pharmacia & Upjohn Spa |
Derivados de ergolina serotoninergicos
|
|
ES2068762B1
(es)
|
1993-07-21 |
1995-12-01 |
Lipotec Sa |
Un nuevo preparado farmaceutico para mejorar la biodisponibilidad de drogas de dificil absorcion y procedimiento para su obtencion.
|
|
US5545617A
(en)
|
1993-11-12 |
1996-08-13 |
The Schepens Eye Research Institute, Inc. |
Therapeutic regulation of abnormal conjunctival goblet cell mucous secretion
|
|
US20060019963A1
(en)
|
1994-06-17 |
2006-01-26 |
Smithkline Beecham Corporation |
Compounds
|
|
AU4613296A
(en)
|
1994-07-25 |
1996-04-19 |
Nda International, Inc. |
A method of treating chemical dependency in mammals and a composition therefor
|
|
US5874477A
(en)
|
1994-08-12 |
1999-02-23 |
The University Of Hawaii |
Method of treatment for malaria utilizing serotonin receptor ligands
|
|
US5696125A
(en)
|
1995-02-24 |
1997-12-09 |
Research Foundation Of The State University Of New York |
Substance abuse-induced hemorrhagic stoke in an animal model
|
|
US5643586A
(en)
|
1995-04-27 |
1997-07-01 |
Perricone; Nicholas V. |
Topical compositions and methods for treatment of skin damage and aging using catecholamines and related compounds
|
|
HUP9700322A3
(en)
|
1995-06-09 |
2001-03-28 |
Euro Celtique Sa |
Formulations and methods for providing prolonged local anesthesia
|
|
US5879690A
(en)
|
1995-09-07 |
1999-03-09 |
Perricone; Nicholas V. |
Topical administration of catecholamines and related compounds to subcutaneous muscle tissue using percutaneous penetration enhancers
|
|
DE19542281C2
(de)
|
1995-11-14 |
1997-12-04 |
Boehringer Ingelheim Kg |
Verwendung von Epinastin für die Behandlung der Migräne
|
|
FR2744362B1
(fr)
|
1996-02-07 |
1998-02-27 |
Rhone Poulenc Rorer Sa |
Application de derives de pyrrolidine a la preparation de medicaments destines au traitement de l'abus de drogues ou de substances donnant lieu a des pharmacomanies ou a un usage excessif
|
|
FR2744363B1
(fr)
|
1996-02-07 |
1998-02-27 |
Rhone Poulenc Rorer Sa |
Application de derives de thiazolidine a la preparation de medicaments destines au traitement de l'abus de drogues ou de substances donnant lieu a des pharmacomanies ou a un usage excessif
|
|
FR2744361B1
(fr)
|
1996-02-07 |
1998-02-27 |
Rhone Poulenc Rorer Sa |
Application de derives de pyrrolidine a la preparation de medicaments destines au traitement de l'abus de drogues ou de substances donnant lieu a des pharmacomanies ou a un usage excessif
|
|
FR2744364B1
(fr)
|
1996-02-07 |
1998-02-27 |
Rhone Poulenc Rorer Sa |
Application d'ureidoacetamides a la preparation de medicaments destines au traitement de l'abus de drogues ou de substances donnant lieu a des pharmacomanies ou a un usage excessif
|
|
WO1997035584A1
(en)
|
1996-03-25 |
1997-10-02 |
Eli Lilly And Company |
Method for treating pain
|
|
TW448171B
(en)
|
1996-06-06 |
2001-08-01 |
Yamanouchi Pharma Co Ltd |
Imidazole-substituted quinoxalinedione derivatives
|
|
WO1997047285A1
(en)
|
1996-06-10 |
1997-12-18 |
Depomed, Inc. |
Gastric-retentive oral controlled drug delivery system with enhanced retention properties
|
|
US5914129A
(en)
|
1996-07-23 |
1999-06-22 |
Mauskop; Alexander |
Analgesic composition for treatment of migraine headaches
|
|
US5902815A
(en)
|
1996-09-03 |
1999-05-11 |
Washington University |
Use of 5HT-2A serotonin agonists to prevent adverse effects of NMDA receptor hypofunction
|
|
US5958919A
(en)
|
1996-09-20 |
1999-09-28 |
Washington University |
Treatment of presymptomatic alzheimer's disease to prevent neuronal degeneration
|
|
US5891885A
(en)
|
1996-10-09 |
1999-04-06 |
Algos Pharmaceutical Corporation |
Method for treating migraine
|
|
US6479074B2
(en)
|
1996-10-24 |
2002-11-12 |
Pharmaceutical Applications Associates Llc |
Methods and transdermal compositions for pain relief
|
|
US5804592A
(en)
|
1997-05-30 |
1998-09-08 |
Unimed Pharmaceuticals, Inc. |
Method for improving disturbed behavior and elevating mood in humans
|
|
IL132784A
(en)
|
1997-05-07 |
2004-07-25 |
Unimed Pharmaceutical Inc |
Pharmaceutical compositions containing dronabinol
|
|
US6558956B1
(en)
|
1997-06-24 |
2003-05-06 |
The University Of Wyoming |
Method and apparatus for detection of a controlled substance
|
|
GB9715082D0
(en)
|
1997-07-17 |
1997-09-24 |
Scherer Ltd R P |
Treatment of attention deficit hyperactivity disorder and narcolepsy
|
|
US7799337B2
(en)
|
1997-07-21 |
2010-09-21 |
Levin Bruce H |
Method for directed intranasal administration of a composition
|
|
US20010004644A1
(en)
|
1997-07-21 |
2001-06-21 |
Levin Bruce H. |
Compositions, kits, apparatus, and methods for inhibiting cephalic inflammation
|
|
AU8915598A
(en)
|
1997-08-25 |
1999-03-16 |
Pentech Pharmaceuticals, Inc. |
Method for amelioration of social phobia
|
|
US7220737B1
(en)
|
1997-09-04 |
2007-05-22 |
Novoneuron, Inc |
Noribogaine in the treatment of pain and drug addiction
|
|
ATE265213T1
(de)
|
1997-09-04 |
2004-05-15 |
Novoneuron Inc |
Noribogain zur behandlung von schmerzen und drogenabhängigkeit
|
|
DE19738855C2
(de)
|
1997-09-05 |
2001-01-04 |
Lohmann Therapie Syst Lts |
Transdermales therapeutisches System mit haftklebender Reservoirschicht und unidirektional elastischer Rückschicht
|
|
US20030077227A1
(en)
|
1997-10-01 |
2003-04-24 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
|
|
US6037346A
(en)
|
1997-10-28 |
2000-03-14 |
Vivus, Inc. |
Local administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction
|
|
US6228864B1
(en)
|
1997-10-28 |
2001-05-08 |
Vivus, Inc. |
Administration of 5-HT receptor agonists and antagonists, to treat premature ejaculation
|
|
WO1999021562A1
(en)
|
1997-10-28 |
1999-05-06 |
Asivi, Llc |
Treatment of female sexual dysfunction
|
|
US5922341A
(en)
|
1997-10-28 |
1999-07-13 |
Vivus, Incorporated |
Local administration of pharmacologically active agents to treat premature ejaculation
|
|
ITTO980264A1
(it)
|
1998-03-26 |
1999-09-26 |
Silvio Rossi |
Applicazione di un estratto basico non quaternario della peschiera fuchsiaefolia ad attivita' antimalarica
|
|
MXPA01000275A
(es)
|
1998-06-22 |
2002-04-24 |
Univ Kingston |
Metodo y composiciones para el tratamiento o alivio de disfunciones sexuales femeninas.
|
|
AU4990599A
(en)
|
1998-07-14 |
2000-02-07 |
Brigham And Women's Hospital |
Upregulation of type iii endothelial cell nitric oxide synthase by agents that disrupt actin cytoskeletal organization
|
|
WO2000003679A2
(en)
|
1998-07-14 |
2000-01-27 |
Adams Food Ltd. |
Nutritionally active composition for hardening fingernails
|
|
WO2000003701A1
(en)
|
1998-07-16 |
2000-01-27 |
Massachusetts Institute Of Technology |
Composition for treatment of stress
|
|
JP2002521432A
(ja)
|
1998-07-31 |
2002-07-16 |
ベラ・ファーマシューティカルズ・インコーポレイテッド |
モクロベマイドを使用する、物質乱用の処置および予防のための方法および組成物
|
|
EP1112106B1
(de)
|
1998-09-18 |
2005-11-23 |
Alcon Manufacturing Ltd. |
5ht2-agoniste zur behandlung des glaukoms
|
|
US20060025387A1
(en)
|
1998-12-23 |
2006-02-02 |
Cytoscan Sciences Llc |
Compositions and methods for the treatment of disorders of the central and peripheral nervous systems
|
|
ES2197600T3
(es)
|
1999-01-29 |
2004-01-01 |
Disphar International B.V. |
Composiciones farmaceuticas.
|
|
BR0008477A
(pt)
|
1999-02-24 |
2002-01-22 |
Univ Cincinnati |
Método para tratar um distúrbio de controle do impulso
|
|
AU3760300A
(en)
|
1999-03-19 |
2000-10-09 |
Brigham And Women's Hospital |
Upregulation of type iii endothelial cell nitric oxide synthase by hmg-coa reductase inhibitors
|
|
WO2000059481A1
(en)
|
1999-04-06 |
2000-10-12 |
Pharmaquest Ltd. |
PHARMACEUTICAL DOSAGE FORM FOR PULSATILE DELIVERY OF d-threo-METHYLPHENIDATE AND A SECOND CNS STIMULANT
|
|
US6383471B1
(en)
|
1999-04-06 |
2002-05-07 |
Lipocine, Inc. |
Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
|
|
BR0009564A
(pt)
|
1999-04-07 |
2002-01-08 |
Pfizer Prod Inc |
Utilização de inibidores da cyp2d6 em terapias de combinação
|
|
US6126924A
(en)
|
1999-05-27 |
2000-10-03 |
Scales-Medeiros; Virginia A. |
Light responsive self-tanning products and methods for use
|
|
US6495498B2
(en)
|
1999-05-27 |
2002-12-17 |
Johnson & Johnson Consumer Companies, Inc. |
Detergent compositions with enhanced depositing, conditioning and softness capabilities
|
|
US6489341B1
(en)
|
1999-06-02 |
2002-12-03 |
Sepracor Inc. |
Methods for the treatment of neuroleptic and related disorders using sertindole derivatives
|
|
US20080103179A1
(en)
|
2006-10-27 |
2008-05-01 |
Tam Peter Y |
Combination Therapy
|
|
US6500459B1
(en)
|
1999-07-21 |
2002-12-31 |
Harinderpal Chhabra |
Controlled onset and sustained release dosage forms and the preparation thereof
|
|
CA2382666A1
(en)
|
1999-08-23 |
2001-03-01 |
The Administrators Of The Tulane Educational Fund |
Modulation of the blood-brain barrier transporter for leptin
|
|
US6204245B1
(en)
|
1999-09-17 |
2001-03-20 |
The Regents Of The University Of California |
Treatment of narcolepsy with immunosuppressants
|
|
AU8003800A
(en)
|
1999-10-08 |
2001-04-23 |
Joyce Corinne Bechthold |
Methods and compositions for treating neurobehavioral disorders
|
|
ES2162746B1
(es)
|
1999-10-21 |
2003-02-16 |
Lipotec Sa |
Microcapsulas para la estabilizacion de productos cosmeticos, farmaceuticos o de alimentacion.
|
|
US6693135B2
(en)
|
2000-01-10 |
2004-02-17 |
Nexmed (Holdings) Incorporated |
Prostaglandin compositions and methods of treatment for male erectile dysfunction
|
|
JP2003520228A
(ja)
|
2000-01-18 |
2003-07-02 |
バリー フォージ ファーマスーティカルズ インコーポレイテッド |
眼の成長及びニコチン性アンタゴニスト
|
|
US20030096831A1
(en)
|
2000-01-18 |
2003-05-22 |
Stone Richard A. |
Ocular growth and nicotinic antagonists
|
|
FR2804603B1
(fr)
|
2000-02-04 |
2004-01-23 |
Rhodia Chimie Sa |
Procede continu pour formuler sous forme de granules une ou plusieurs matieres actives pharmaceutiques
|
|
US20020015730A1
(en)
|
2000-03-09 |
2002-02-07 |
Torsten Hoffmann |
Pharmaceutical formulations and method for making
|
|
WO2001067890A2
(en)
|
2000-03-14 |
2001-09-20 |
Massachusetts Institute Of Technology |
Composition and method to treat weight gain and obesity attributable to psychotropic drugs
|
|
DE10014588A1
(de)
|
2000-03-27 |
2001-10-04 |
Basf Ag |
Wirkstoffhaltige Schwimmformen enthaltend Polyvinylacetat und Polyvinylpyrrolidon, deren Verwendung und Herstellung
|
|
WO2001072839A2
(en)
|
2000-03-27 |
2001-10-04 |
Pe Corporation (Ny) |
Human g-protein coupled receptors
|
|
US6380176B2
(en)
|
2000-03-28 |
2002-04-30 |
Ajinomoto Co., Inc. |
Method for inhibiting non-intentional behavior with a running neuron inhibitory substance
|
|
DE10018834A1
(de)
|
2000-04-15 |
2001-10-25 |
Lohmann Therapie Syst Lts |
Transdermale oder transmucosale Darreichungsformen mit einer nicotinhaltigen Wirkstoffkombination zur Raucherentwöhnung
|
|
WO2001082915A2
(en)
|
2000-04-28 |
2001-11-08 |
Neal Gary W |
Trans-clitoral administration of therapy
|
|
DE60133270T2
(de)
|
2000-05-10 |
2009-04-23 |
Jagotec Ag |
Zerkleinerung mittels mahlkörper
|
|
US20020044962A1
(en)
|
2000-06-06 |
2002-04-18 |
Cherukuri S. Rao |
Encapsulation products for controlled or extended release
|
|
US20070059367A1
(en)
|
2000-06-06 |
2007-03-15 |
Cherukuri S R |
Drug Delivery System and Associated Methods
|
|
US20020019421A1
(en)
|
2000-07-05 |
2002-02-14 |
Roni Biberman |
Compositions and therapy for substance addiction
|
|
AU2001281416A1
(en)
|
2000-07-19 |
2002-01-30 |
Pitmy International N.V. |
Transportation of nucleic acid substances
|
|
US7229784B2
(en)
|
2000-09-19 |
2007-06-12 |
Microbia, Inc. |
Modulation of secondary metabolite production by zinc binuclear cluster proteins
|
|
US9474776B2
(en)
|
2000-10-04 |
2016-10-25 |
Paul Edward Stamets |
Integrative fungal solutions for protecting bees
|
|
US9399050B2
(en)
|
2000-10-04 |
2016-07-26 |
Paul Edward Stamets |
Controlling insects and arthropods using preconidial mycelium and extracts of preconidial mycelium from entomopathogenic fungi
|
|
US20070099999A1
(en)
|
2000-11-01 |
2007-05-03 |
Epstein Mel H |
Methods of treating depression
|
|
US20030119884A1
(en)
|
2000-11-01 |
2003-06-26 |
Epstein Mel H. |
Methods and compositions for regulating memory consolidation
|
|
CA2359812C
(en)
|
2000-11-20 |
2004-02-10 |
The Procter & Gamble Company |
Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
|
|
AR031473A1
(es)
|
2000-11-20 |
2003-09-24 |
Lundbeck & Co As H |
Intensificadores de gaba en el tratamiento de enfermedades relacionadas con una reducida actividad neuroesteroide
|
|
US6495154B1
(en)
|
2000-11-21 |
2002-12-17 |
Vivus Inc. |
On demand administration of clomipramine and salts thereof to treat premature ejaculation
|
|
IL139975A0
(en)
|
2000-11-29 |
2002-02-10 |
Univ Ramot |
Anti proliferative drugs
|
|
EE200300249A
(et)
|
2000-11-30 |
2003-10-15 |
Pfizer Products Inc. |
GABA agonistide ja aldoosreduktaasi inhibiitoritekombinatsioon
|
|
EP1337271B1
(de)
|
2000-11-30 |
2004-11-03 |
Pfizer Products Inc. |
Kombination von gaba agonisten und sorbitol dehydrogenase inhibitoren
|
|
US20050176790A1
(en)
|
2001-02-28 |
2005-08-11 |
Johannes Bartholomaus |
Pharmaceutical salts
|
|
US20020137785A1
(en)
|
2001-03-26 |
2002-09-26 |
George Kindness |
Inflammatory mechanism modulator composition and methods with anti-asthmatic properties
|
|
US20050096396A1
(en)
|
2002-03-28 |
2005-05-05 |
Emory University |
Acute pharmacologic augmentation of psychotherapy with enhancers of learning or conditioning
|
|
AU2002305123B2
(en)
|
2001-03-30 |
2006-10-05 |
Philadelphia Health And Education Corporation |
Immunomodulation and effect on cell processes relating to serotonin family receptors
|
|
US6632217B2
(en)
|
2001-04-19 |
2003-10-14 |
Microsolutions, Inc. |
Implantable osmotic pump
|
|
JP2005503346A
(ja)
|
2001-05-04 |
2005-02-03 |
メルク エンド カムパニー インコーポレーテッド |
片頭痛を治療するための方法及び組成物
|
|
US7766013B2
(en)
|
2001-06-05 |
2010-08-03 |
Alexza Pharmaceuticals, Inc. |
Aerosol generating method and device
|
|
US20040023952A1
(en)
|
2001-06-20 |
2004-02-05 |
Leventhal Audie G. |
Enhanced brain function by gaba-ergic stimulation
|
|
WO2003016903A2
(de)
|
2001-08-20 |
2003-02-27 |
Walter Pils |
Vorrichtung und verfahren zum nachweis eines analyten
|
|
US6541043B2
(en)
|
2001-08-28 |
2003-04-01 |
Dexgen Pharmaceuticals, Inc. |
Method and synergistic composition for treating attention deficit/hyperactivity disorder
|
|
EP1429728A1
(de)
|
2001-08-29 |
2004-06-23 |
SRL Technologies, Inc. |
Zubereitungen mit verzögerter freisetzung
|
|
ATE447967T1
(de)
|
2001-09-14 |
2009-11-15 |
Cytos Biotechnology Ag |
Verpackung von immunstimulierendem cpg in virusähnlichen partikeln: herstellungsverfahren und verwendung
|
|
WO2003024480A2
(en)
|
2001-09-14 |
2003-03-27 |
Cytos Biotechnology Ag |
In vivo activation of antigen presenting cells for enhancement of immune responses induced by virus like particles
|
|
KR20040039436A
(ko)
|
2001-09-27 |
2004-05-10 |
파마시아 에이비 |
약학 조성물
|
|
US7544681B2
(en)
|
2001-09-27 |
2009-06-09 |
Ramot At Tel Aviv University Ltd. |
Conjugated psychotropic drugs and uses thereof
|
|
US6592901B2
(en)
|
2001-10-15 |
2003-07-15 |
Hercules Incorporated |
Highly compressible ethylcellulose for tableting
|
|
US20060264508A1
(en)
|
2001-10-16 |
2006-11-23 |
Stone Richard A |
Modulation of ocular growth and myopia by gaba drugs
|
|
US20030082225A1
(en)
|
2001-10-19 |
2003-05-01 |
Mason Paul Arthur |
Sterile, breathable patch for treating wound pain
|
|
US7045543B2
(en)
|
2001-11-05 |
2006-05-16 |
Enzrel Inc. |
Covalent conjugates of biologically-active compounds with amino acids and amino acid derivatives for targeting to physiologically-protected sites
|
|
AU2002340439A1
(en)
|
2001-11-09 |
2003-05-26 |
Chiron Corporation |
Method of vaccinating a human patient to prevent metastatic tumors
|
|
GB0127832D0
(en)
|
2001-11-20 |
2002-01-09 |
Jagotec Ag |
Method for the preparation of pharmaceutical nanosuspensions
|
|
CA2468015A1
(en)
|
2001-11-27 |
2003-06-05 |
Merck & Co., Inc. |
2-aminoquinoline compounds
|
|
WO2003045920A1
(en)
|
2001-11-27 |
2003-06-05 |
Merck & Co., Inc. |
4-aminoquinoline compounds
|
|
EP1509204A4
(de)
|
2001-11-29 |
2005-07-13 |
Rettenmaier & Soehne Gmbh & Co |
Agglomerierte teilchen mit einem wirkstoff, der zusammen mit verkieselter mikrokristalliner cellulose aufbereitet wird
|
|
US7241797B2
(en)
|
2002-01-23 |
2007-07-10 |
University Of Cincinnati |
Method of increasing milk production
|
|
US20030171435A1
(en)
|
2002-01-23 |
2003-09-11 |
Drug Abuse Sciences, Inc. |
New amphetamine derivatives, antibodies against them and pharmaceutical compositions containing them
|
|
EP1480624B1
(de)
|
2002-02-07 |
2006-11-29 |
Pharmacia Corporation |
Pharmazeutische tablette
|
|
NZ534340A
(en)
|
2002-02-07 |
2006-04-28 |
Pharmacia Corp |
Pharmaceutical dosage form for mucosal delivery
|
|
US20030153552A1
(en)
|
2002-02-14 |
2003-08-14 |
Mash Deborah C. |
Method of treating chemical dependency in mammals and a composition therefor
|
|
US7700561B2
(en)
|
2002-02-22 |
2010-04-20 |
Shire Llc |
Abuse-resistant amphetamine prodrugs
|
|
WO2006121552A2
(en)
|
2005-04-08 |
2006-11-16 |
New River Pharmaceuticals Inc. |
Abuse-resistant amphetamine prodrugs
|
|
DE10208335A1
(de)
|
2002-02-27 |
2003-09-04 |
Roehm Gmbh |
Arzneiform und Verfahren zu ihrer Herstellung
|
|
US20030199439A1
(en)
|
2002-04-22 |
2003-10-23 |
Simon David Lew |
Compositions of alpha3beta4 receptor antagonists and opioid agonist analgesics
|
|
WO2003090743A1
(en)
|
2002-04-24 |
2003-11-06 |
Cypress Bioscience, Inc. |
Prevention and treatment of functional somatic disorders, including stress-related disorders
|
|
US20060034872A1
(en)
|
2002-04-29 |
2006-02-16 |
Woolf Clifford J |
Compositions and methods for preventing abuse of orally administered medications
|
|
AUPS317102A0
(en)
|
2002-06-25 |
2002-07-18 |
Drug Delivery Solutions Pty Ltd |
Transdermal aerosol compositions
|
|
EP1539208A2
(de)
|
2002-06-28 |
2005-06-15 |
Nastech Pharmaceutical Company Inc. |
ZUSAMMENSETZUNGEN UND VERFAHREN ZUR MODULIERUNG DER PHYSIOLOGIE VON EPITHEL-VERBINDUNGS-ADHûSIONSMOLEK LEN ZUR VERBESSERTEN MUKOSALEN ABGABE VON THERAPEUTISCHEN MITTELN
|
|
US20040006043A1
(en)
|
2002-07-02 |
2004-01-08 |
Ramot University Authority For Applied Research & Industrial Development Ltd. |
Methods, pharmaceutical compositions and pharmaceutical kits for enhancing the therapeutic efficiency of cancer chemotherapeutic agents
|
|
US10738268B2
(en)
|
2016-08-21 |
2020-08-11 |
Insectergy, Llc |
Cannabis nanoemulsion methods
|
|
US20050148673A1
(en)
|
2002-07-11 |
2005-07-07 |
Harbut Ronald E. |
Prolonged administration of NMDA antagonist and safener drug to alter neuropathic pain condition
|
|
BR0312935A
(pt)
|
2002-07-17 |
2005-06-21 |
Cytos Biotechnology Ag |
Partìcula semelhante a vìrus, muteìna, vetores para produzir a referida partìcula e proteìna recombinante, composição, processo para produção de fileira ordena e repetitva de antìgeno, molécula de ácido nucléico, célula hospedeira, método para produção da referida partìcula e uso da composição de vacina
|
|
BR0312297A
(pt)
|
2002-07-18 |
2005-04-12 |
Cytos Biotechnology Ag |
Conjugados veìculos de hapteno e seu uso
|
|
US7838034B2
(en)
|
2002-07-30 |
2010-11-23 |
Grunenthal Gmbh |
Intravenous pharmaceutical form of administration
|
|
WO2004014429A1
(ja)
|
2002-08-09 |
2004-02-19 |
Mitsubishi Pharma Corporation |
精神疾患発症脆弱性制御剤
|
|
US20030114512A1
(en)
|
2002-09-09 |
2003-06-19 |
Collier Robert J |
Compounds with 5-ht2 and 5-ht1a agonist activity for treating glaucoma
|
|
WO2004025268A2
(en)
|
2002-09-13 |
2004-03-25 |
Carnegie Mellon University |
Optical biosensors and methods of use thereof
|
|
EP1542665A1
(de)
|
2002-09-19 |
2005-06-22 |
Merck & Co., Inc. |
VERFAHREN ZUR BEHANDLUNG VON DEPRESSION UND/ODER ANGSTZUSTûNDEN
|
|
US6913768B2
(en)
|
2002-09-24 |
2005-07-05 |
Shire Laboratories, Inc. |
Sustained release delivery of amphetamine salts
|
|
DE10244504A1
(de)
|
2002-09-25 |
2004-04-08 |
Capsulution Nanoscience Ag |
Schnellfreisetzende Darreichungsform mit schwerlöslichem Wirkstoff
|
|
EP1551370B1
(de)
|
2002-10-11 |
2007-12-19 |
Idea Ag |
Aggregate mit erhöhter verformbarkeit, aus mindestens drei amphiphilen bestehend, zum verbesserten transport durch teildurchlässigen barrieren und zur nichtinvasiven verabreichung von medikamenten in vivo, insbesondere durch die haut
|
|
AU2003304211A1
(en)
|
2002-10-30 |
2005-01-04 |
The Regents Of The University Of California |
Direct micro-patterning of lipid bilayers using uv light and selected uses thereof
|
|
DE10250944B9
(de)
|
2002-10-31 |
2004-09-16 |
Cell Center Cologne Gmbh |
Verwendung eines Stifts zur Applikation von Pflege- oder Wirkstoffen in die Nase
|
|
US7670627B2
(en)
|
2002-12-09 |
2010-03-02 |
Salvona Ip Llc |
pH triggered targeted controlled release systems for the delivery of pharmaceutical active ingredients
|
|
AU2003292936A1
(en)
|
2002-12-24 |
2004-07-22 |
Neurochem (International) Limited |
Therapeutic formulations for the treatment of beta-amyloid related diseases
|
|
MXPA05007568A
(es)
|
2003-01-16 |
2005-09-21 |
Acadia Pharm Inc |
Agonistas inversos del receptor selectivo de serotonina 2a/2c como terapeuticos para enfermedades neurodegenerativas.
|
|
MXPA05007784A
(es)
|
2003-01-23 |
2005-09-30 |
Acadia Pharm Inc |
Empleo de la n-desmetilclozapina para tratar las enfermedades neuropsiquiatricas humanas.
|
|
US20040186155A1
(en)
|
2003-01-30 |
2004-09-23 |
Dayno Jeffrey Marc |
Combination therapy for the treatment or prevention of migraine
|
|
EP1603548A4
(de)
|
2003-02-05 |
2007-10-10 |
Myriad Genetics Inc |
Verfahren und zusammensetzung zur behandlung neurodegenerativer erkrankungen
|
|
US20040214215A1
(en)
|
2003-03-07 |
2004-10-28 |
Yu Ruey J. |
Bioavailability and improved delivery of alkaline pharmaceutical drugs
|
|
WO2004082624A2
(en)
|
2003-03-17 |
2004-09-30 |
Neurohealing Pharmaceuticals, Inc. |
Modafinil-based neurorehabilitation of impaired neurological function associated with injury
|
|
NZ542323A
(en)
|
2003-03-26 |
2008-07-31 |
Cytos Biotechnology Ag |
Melan-A peptide analogue-virus-like-particle conjugates
|
|
US8906413B2
(en)
|
2003-05-12 |
2014-12-09 |
Supernus Pharmaceuticals, Inc. |
Drug formulations having reduced abuse potential
|
|
AU2004251647B2
(en)
|
2003-05-29 |
2010-01-14 |
Takeda Pharmaceutical Company Limited |
Abuse resistant amphetamine compounds
|
|
US20060240014A1
(en)
|
2003-06-03 |
2006-10-26 |
Beth Israel Deaconess Medical Center |
Methods and compounds for the treatment of vascular stenosis
|
|
WO2004112723A2
(en)
|
2003-06-20 |
2004-12-29 |
Ronald Aung-Din |
Tropical therapy for the treatment of migraines, muscle sprains, muscle spasm, spasticity and related conditions
|
|
JP4174016B2
(ja)
|
2003-07-11 |
2008-10-29 |
株式会社ビーエル |
競合法によるサイロシン類のイムノクロマトグラフィー検出法及びテストキット
|
|
WO2005007111A2
(en)
|
2003-07-11 |
2005-01-27 |
Bristol-Myers Squibb Company |
Tetrahydroquinoline derivatives as cannabinoid receptor modulators
|
|
DE10334188B4
(de)
|
2003-07-26 |
2007-07-05 |
Schwarz Pharma Ag |
Verwendung von Rotigotin zur Behandlung von Depressionen
|
|
DE10338174A1
(de)
|
2003-08-20 |
2005-03-24 |
Lts Lohmann Therapie-Systeme Ag |
Transdermale Arzneimittelzubereitungen mit Wirkstoffkombinationen zur Behandlung der Parkinson-Krankheit
|
|
US20050203011A1
(en)
|
2003-09-19 |
2005-09-15 |
The Regents Of The University Of California |
Mitigating symptoms and behaviors of substance abuse by modulating GDNF or BDNF pathway activity
|
|
US20050070501A1
(en)
|
2003-09-29 |
2005-03-31 |
New York Blood Center, Inc. |
Water dispersible film
|
|
ES2365847T3
(es)
|
2003-10-03 |
2011-10-11 |
Veijlen N.V. |
Uso de derivados del ácido indolacético que aumentan la concentración sérica de igf-1 para la preparación de una composición terapéutica para el tratamiento de diversas enfermedades.
|
|
US7517900B2
(en)
|
2003-10-10 |
2009-04-14 |
Bristol-Myers Squibb Company |
Pyrazole derivatives as cannabinoid receptor modulators
|
|
WO2005039502A2
(en)
|
2003-10-24 |
2005-05-06 |
Azopax Therapeutics Llc |
Macromer-melt formulations
|
|
US20070053954A1
(en)
|
2003-10-24 |
2007-03-08 |
Rowe Stephen C |
Macromer-melt formulations
|
|
JP2005132747A
(ja)
|
2003-10-29 |
2005-05-26 |
Ajinomoto Co Inc |
老齢伴侶動物の老化行動改善剤
|
|
US8334263B2
(en)
|
2003-12-16 |
2012-12-18 |
Raymond Nadeson |
Analgesic methods and compositions
|
|
US20050260258A1
(en)
|
2003-12-18 |
2005-11-24 |
The Texas A&M University System |
Use of vitelline protein B as a microencapsulating additive
|
|
WO2005063248A1
(en)
|
2003-12-22 |
2005-07-14 |
Sepracor Inc. |
Modafinil combination therapy for improving sleep quality
|
|
JP2007516275A
(ja)
|
2003-12-23 |
2007-06-21 |
ファイザー・プロダクツ・インク |
認知増強および精神病性障害のための治療的組合せ
|
|
GB0400802D0
(en)
|
2004-01-14 |
2004-02-18 |
Daniolabs Ltd |
Compounds for the treatment of disease
|
|
CA2554959A1
(en)
|
2004-01-29 |
2005-08-11 |
Neuromolecular, Inc. |
Combination of a nmda receptor antagonist and a mao-inhibitor or a gadpf-inhibitor for the treatment of central nervous system-related conditions
|
|
CA2556216A1
(en)
|
2004-02-13 |
2005-09-01 |
Neuromolecular, Inc. |
Combination of a nmda receptor antagonist and an anti-depressive drug mao-inhibitor or a gadph-inhibitor for the treatment of psychiatric conditions
|
|
WO2005079773A2
(en)
|
2004-02-13 |
2005-09-01 |
Neuromolecular, Inc. |
Combination of an nmda receptor antagonist and an anti-epileptic drug for the treatment of epilepsy and other cns disorders
|
|
WO2005082277A1
(en)
|
2004-02-18 |
2005-09-09 |
Stanford University |
Drug delivery systems using mesoporous oxide films
|
|
US20050222270A1
(en)
|
2004-02-26 |
2005-10-06 |
Olney John W |
Prolonged administration of NMDA antagonist drug and safener drug to create improved stable neural homeostasis
|
|
FR2867075B1
(fr)
|
2004-03-03 |
2006-07-14 |
Ethypharm Sa |
Procede de preparation de microspheres biodegradables calibrees
|
|
CA2559207A1
(en)
|
2004-03-12 |
2005-09-29 |
The Mclean Hospital Corporation |
Salvinorin derivatives and uses thereof
|
|
US20060270592A1
(en)
|
2004-03-19 |
2006-11-30 |
Ophthalmic Research Associates, Inc. |
Use of neurotransmitters and neuropeptides for the treatment of dry eye diseases and related conditions
|
|
WO2005102366A2
(en)
|
2004-04-19 |
2005-11-03 |
Philip Maxwell Satow |
Lithium combinations, and uses related thereto
|
|
WO2005102390A2
(en)
|
2004-04-22 |
2005-11-03 |
Pfizer Japan, Inc. |
Combinations comprising alpha-2-delta ligands and nmda receptor antagonists
|
|
RU2253461C1
(ru)
|
2004-04-30 |
2005-06-10 |
Общество с ограниченной ответственностью "Паркинфарм" |
Фармацевтическая комбинация, оказывающая влияние на функционирование цнс, способ коррекции состояний, связанных с нарушениями функционирования цнс; фармацевтический набор; средство, способствующее проникновению через гематоэнцефалический барьер лекарственных субстанций и метаболитов; фармацевтическое средство для эндоназального применения
|
|
US20050255091A1
(en)
|
2004-05-14 |
2005-11-17 |
Loomis Gary L |
Hydrogels for biomedical applications
|
|
US20050261278A1
(en)
|
2004-05-21 |
2005-11-24 |
Weiner David M |
Selective serotonin receptor inverse agonists as therapeutics for disease
|
|
US20050265955A1
(en)
|
2004-05-28 |
2005-12-01 |
Mallinckrodt Inc. |
Sustained release preparations
|
|
NL1026634C2
(nl)
|
2004-07-12 |
2006-01-16 |
Willem Jacob Van Der Burg |
Psychofarmaceutisch preparaat en werkzame stof daarin.
|
|
US7799802B2
(en)
|
2004-08-03 |
2010-09-21 |
Institstute of Oriental Medical Science Inc. |
Method and health food for preventing and/or alleviating psychiatric disorder, and/or for effectuating sedation
|
|
US20060030625A1
(en)
|
2004-08-06 |
2006-02-09 |
Cheryle Ram Hart |
Dietary neurotransmitter precursors for balanced synthesis of neurotransmitters
|
|
US20060045865A1
(en)
|
2004-08-27 |
2006-03-02 |
Spherics, Inc. |
Controlled regional oral delivery
|
|
DE602005024850D1
(de)
|
2004-09-24 |
2010-12-30 |
Beth Israel Hospital |
Verfahren zur diagnose und behandlung von schwangerschaftsskomplikationen
|
|
AU2005300045A1
(en)
|
2004-09-27 |
2006-05-04 |
Organix, Inc. |
Indole compounds useful as serotonin selective agents
|
|
US20060240043A1
(en)
|
2004-10-08 |
2006-10-26 |
Meyerson Laurence R |
Methods and compositions for treating migraine pain
|
|
CN101107013A
(zh)
|
2004-11-22 |
2008-01-16 |
阿纳迪斯有限公司 |
生物活性组合物
|
|
FR2878161B1
(fr)
|
2004-11-23 |
2008-10-31 |
Flamel Technologies Sa |
Forme medicamenteuse orale, solide et concue pour eviter le mesusage
|
|
US20060110327A1
(en)
|
2004-11-24 |
2006-05-25 |
Acura Pharmaceuticals, Inc. |
Methods and compositions for deterring abuse of orally administered pharmaceutical products
|
|
FR2878158B1
(fr)
|
2004-11-24 |
2009-01-16 |
Flamel Technologies Sa |
Forme pharmaceutique orale, microparticulaire solide concue pour eviter le mesusage
|
|
US7294649B2
(en)
|
2004-12-17 |
2007-11-13 |
Roche Diagnostics Operatins, Inc. |
Methamphetamine derivatives and conjugates for immunoassay
|
|
US8512751B2
(en)
|
2004-12-20 |
2013-08-20 |
Collegium Pharmaceutical, Inc. |
Pharmaceutical compositions for sleep disorders
|
|
WO2007066240A2
(en)
|
2005-01-10 |
2007-06-14 |
Smiths Detection Inc. |
Sampling swab
|
|
DE102005004343A1
(de)
|
2005-01-25 |
2006-08-10 |
Eberhard-Karls-Universität Tübingen Universitätsklinikum |
Behandlung von Phantomphänomenen
|
|
FR2881652B1
(fr)
|
2005-02-08 |
2007-05-25 |
Flamel Technologies Sa |
Forme pharmaceutique orale microparticulaire anti-mesuage
|
|
US8318210B2
(en)
|
2005-02-28 |
2012-11-27 |
Neos Therapeutics, Lp |
Compositions and methods of making sustained release liquid formulations
|
|
ES2573539T3
(es)
|
2005-03-21 |
2016-06-08 |
Teva Czech Industries S.R.O. |
Inhibidor de la cristalización y su uso en cápsulas de gelatina
|
|
WO2006103407A2
(en)
|
2005-03-28 |
2006-10-05 |
Orexo Ab |
New pharmaceutical compositions useful in the treatment of migraine
|
|
US20060229293A1
(en)
|
2005-04-06 |
2006-10-12 |
Addiction Research Institute, Inc. |
Compositions for the treatment of hepatitis C and methods for using compositions for the treatment of hepatitis C
|
|
CA2604696C
(en)
|
2005-04-15 |
2015-03-24 |
Interface Biologics, Inc. |
Polymer-biologically active agent complexes for localized delivery of said biologically active agent
|
|
WO2006113485A2
(en)
|
2005-04-15 |
2006-10-26 |
Board Of Trustees Of Michigan State University |
Aminergic pharmaceutical compositions and methods
|
|
GT200600159A
(es)
|
2005-04-22 |
2007-03-14 |
|
Derivados benzodioxano y benzodioxolano y usos de los mismos
|
|
CA2607576C
(en)
|
2005-05-06 |
2013-07-09 |
Smiths Detection Inc. |
Improved chemical identification of peroxide-based explosives
|
|
US8859585B2
(en)
|
2005-05-25 |
2014-10-14 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Scopolamine for the treatment of depression and anxiety
|
|
GB0511060D0
(en)
|
2005-05-31 |
2005-07-06 |
Novartis Ag |
Organic compounds
|
|
ES2400772T3
(es)
|
2005-06-07 |
2013-04-12 |
Ramot At Tel Aviv University Ltd. |
Sales novedosas de fármacos psicotrópicos conjugados y procedimientos para la preparación de las mismas
|
|
EP2371394A1
(de)
|
2005-06-16 |
2011-10-05 |
Mohammed Saeed |
Zusammensetzung und Verfahren zur Hemmung, Verhinderung oder Linderung von Komplikationen, die mit dem Verschlucken eines medizinischen, chemischen oder biologischen Stoffes oder Mittels zusammenhängen
|
|
US7645802B2
(en)
|
2005-06-27 |
2010-01-12 |
Biovail Laboratories International Srl. |
Bupropion hydrobromide and therapeutic applications
|
|
US9198862B2
(en)
|
2005-07-22 |
2015-12-01 |
Rubicon Research Private Limited |
Dispersible tablet composition
|
|
US8852638B2
(en)
|
2005-09-30 |
2014-10-07 |
Durect Corporation |
Sustained release small molecule drug formulation
|
|
US20070092586A1
(en)
|
2005-10-26 |
2007-04-26 |
Alamo Pharmaceuticals |
Compositions and methods for the administration psychotropic drugs which modulate body weight
|
|
DE102005055866A1
(de)
|
2005-11-23 |
2007-05-24 |
Hte Ag The High Throughput Experimentation Company |
Verfahren zur Herstellung von Aryl-Aryl gekoppelter Verbindungen
|
|
JP2009523833A
(ja)
|
2006-01-21 |
2009-06-25 |
アボット ゲーエムベーハー ウント カンパニー カーゲー |
乱用薬剤送達のための製剤および方法
|
|
CN101336116B
(zh)
|
2006-02-02 |
2013-01-02 |
医学技术设备公司 |
一种包含溶胶-凝胶组合物的生物活性物质输送系统
|
|
US20070203216A1
(en)
|
2006-02-14 |
2007-08-30 |
Bjarke Ebert |
Method of treating inflammatory diseases
|
|
US20070190130A1
(en)
|
2006-02-16 |
2007-08-16 |
Mark William A |
Protein hydrolysate excipients
|
|
US20080075789A1
(en)
|
2006-02-28 |
2008-03-27 |
The Regents Of The University Of California |
Genes differentially expressed in bipolar disorder and/or schizophrenia
|
|
EP1998788A4
(de)
|
2006-03-01 |
2011-08-03 |
Ruey J Yu |
Zusammensetzung und verfahren zur topischen behandlung teer-responsiver hauterkrankungen
|
|
FR2898271B1
(fr)
|
2006-03-09 |
2009-01-16 |
Pierre Fabre Medicament Sa |
Nouvelle utilisation d'agents antihistaminiques pour le traitement preventif ou procede de syndromes inflammatoires, en particulier ceux declenches par les toga virus.
|
|
US8785500B2
(en)
|
2006-03-22 |
2014-07-22 |
Icahn School Of Medicine At Mount Sinai |
Intranasal administration of ketamine to treat depression
|
|
WO2006079999A2
(en)
|
2006-04-09 |
2006-08-03 |
Barth Frederik H |
Induction of a novel state of mind with a 5-ht2a agonist and a nmda antagonist
|
|
WO2007148230A2
(en)
|
2006-04-14 |
2007-12-27 |
Interface Biologics Incorporated |
Grafted polymers and uses thereof
|
|
GB0608647D0
(en)
|
2006-05-02 |
2006-06-14 |
Haritou Susan J A |
Methods of diagnosis and treatment
|
|
MX2008014455A
(es)
|
2006-05-12 |
2008-11-27 |
Shire Llc |
Sistema de suministro de farmaco de dosis controlada.
|
|
US8846100B2
(en)
|
2006-05-12 |
2014-09-30 |
Shire Llc |
Controlled dose drug delivery system
|
|
PL1948155T3
(pl)
|
2006-06-28 |
2012-10-31 |
Chelsea Therapeutics Inc |
Kompozycje farmaceutyczne zawierające droksidopę
|
|
CA2656112A1
(en)
|
2006-06-30 |
2008-05-08 |
Hanje Chen |
Bioresponsive polymers
|
|
KR20090048462A
(ko)
|
2006-07-17 |
2009-05-13 |
라모트 앳 텔-아비브 유니버시티 리미티드 |
통증완화용 ｇａｂａ 접합체
|
|
CA2692440A1
(en)
|
2006-07-20 |
2008-01-24 |
Cascade Therapeutics Inc. |
Tetrahydro-5h-pyrido[2,3-d]azepines as 5-ht2c ligands
|
|
US20080026189A1
(en)
|
2006-07-27 |
2008-01-31 |
Chun-Wei Lin |
Thin key structure for generating dazzling light
|
|
EP2053919B1
(de)
|
2006-08-23 |
2013-12-25 |
The University Of Montana |
Verfahren zur reduzierung von schädigungen der nervenzellen
|
|
SA07280459B1
(ar)
|
2006-08-25 |
2011-07-20 |
بيورديو فارما إل. بي. |
أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
|
|
WO2008026046A1
(en)
|
2006-08-30 |
2008-03-06 |
Pfizer Products Inc. |
Morpholine d3 dopamine antagonists
|
|
JP2010502623A
(ja)
|
2006-08-31 |
2010-01-28 |
バイオジェン・アイデック・エムエイ・インコーポレイテッド |
Ｎｏｇｏレセプターポリペプチドの末梢投与に関する方法
|
|
AU2007299920A1
(en)
|
2006-09-19 |
2008-03-27 |
Braincells, Inc. |
PPAR Mediated Modulation of Neurogenesis
|
|
US20080066739A1
(en)
|
2006-09-20 |
2008-03-20 |
Lemahieu Edward |
Methods and systems of delivering medication via inhalation
|
|
CA2664935A1
(en)
|
2006-09-26 |
2008-04-03 |
Addiction Research Institute, Inc. |
Compositions for the treatment of hepatitis c and methods for using compositions for the treatment of hepatitis c
|
|
WO2008038291A1
(en)
|
2006-09-27 |
2008-04-03 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Combination of liposomal anti-cancer drugs and lysosome/endosome ph increasing agents for therapy
|
|
CN101646432A
(zh)
|
2006-10-27 |
2010-02-10 |
詹森药业有限公司 |
治疗破坏性行为障碍的方法
|
|
MX2009004516A
(es)
|
2006-10-27 |
2009-08-12 |
Medivation Neurology Inc |
Metodos y terapias de combinacion para tratar enfermedad de alzheimer.
|
|
EP2089011A1
(de)
|
2006-10-31 |
2009-08-19 |
Janssen Pharmaceutica N.V. |
Behandlung pervasiver entwicklungsstörungen
|
|
US8653106B2
(en)
|
2010-07-30 |
2014-02-18 |
Pisgah Laboratories, Inc. |
Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder
|
|
US20080293695A1
(en)
|
2007-05-22 |
2008-11-27 |
David William Bristol |
Salts of physiologically active and psychoactive alkaloids and amines simultaneously exhibiting bioavailability and abuse resistance
|
|
US7718649B1
(en)
|
2006-11-10 |
2010-05-18 |
Pisgah Labs, Inc. |
Physical states of a pharmaceutical drug substance
|
|
ATE509622T1
(de)
|
2006-12-11 |
2011-06-15 |
Kempharm Inc |
Amphetamin-ornithine konjugate sowie herstellungs-und verwendungsverfahren
|
|
ES2302650B1
(es)
|
2007-01-11 |
2009-02-16 |
Tedec-Meiji Farma, S.A. |
Composicion de rapida desintegracion en la cavidad bucal.
|
|
US20100076006A1
(en)
|
2007-01-31 |
2010-03-25 |
University Of Virginia Patent Foundation |
Topiramate Plus Naltrexone for the Treatment of Addictive Disorders
|
|
EP2433654A3
(de)
|
2007-02-08 |
2013-05-15 |
Kempharm, Inc. |
Citrullin und Homocitrullin Prodrugs von Amphetaminen und Verfahren zur deren Herstellung
|
|
BRPI0808647A2
(pt)
|
2007-03-09 |
2014-08-12 |
Chelsea Therapeutics Inc |
Método para tratar a síndrome de sensibilidade central, método para reduzir, eliminar ou prevenir a dor associada à fibromialgia, kit útil para o tratamento de uma síndrome de sensibilidade central.
|
|
WO2008112773A2
(en)
|
2007-03-12 |
2008-09-18 |
Chelsea Therapeutics, Inc. |
Droxidopa and pharmaceutical composition thereof for the treatment of neurally mediated hypotension
|
|
WO2008115797A1
(en)
|
2007-03-16 |
2008-09-25 |
Pavo, Inc. |
Therapeutic compositions and methods
|
|
DE102007014286A1
(de)
|
2007-03-19 |
2008-09-25 |
Universität Tübingen |
Fluorsubstituierte Amphetamine und Amphetaminderivate und deren Verwendung
|
|
CA2682432C
(en)
|
2007-03-30 |
2017-06-06 |
Duke University |
Device and method for delivery of a medicament
|
|
AT505086B1
(de)
|
2007-04-02 |
2009-06-15 |
Planta Naturstoffe Vertriebsge |
Pharmazeutisches mittel gegen juckreiz und juckreizbedingten schmerz
|
|
WO2008122990A1
(en)
|
2007-04-04 |
2008-10-16 |
Almet Corporation Limited |
Compacting upflow extractor and method of using it
|
|
WO2008128193A1
(en)
|
2007-04-12 |
2008-10-23 |
Rutgers, The State University Of New Jersey |
Biodegradable polyanhydrides with natural bioactive molecules
|
|
JP2009531466A
(ja)
|
2007-04-18 |
2009-09-03 |
テバ ファーマシューティカル インダストリーズ リミティド |
ＨＭＧ−ＣｏＡ還元酵素阻害剤の中間体の製造方法
|
|
US7638651B2
(en)
|
2007-04-26 |
2009-12-29 |
Auspex Pharmaceuticals |
Substituted cyclohexanones
|
|
US9421266B2
(en)
|
2007-05-22 |
2016-08-23 |
Pisgah Laboratories, Inc. |
Safety of pseudoephedrine drug products
|
|
US10183001B1
(en)
|
2007-05-22 |
2019-01-22 |
Pisgah Laboratories, Inc. |
Opioid and attention deficit hyperactivity disorder medications possessing abuse deterrent and anti-dose dumping safety features
|
|
CA2693338A1
(en)
|
2007-07-31 |
2009-02-05 |
Limerick Biopharma, Inc. |
Phosphorylated pyrone analogs and methods
|
|
EA018064B1
(ru)
|
2007-08-03 |
2013-05-30 |
Рихтер Гедеон Нирт. |
Способ лечения депрессии
|
|
EP2182804B1
(de)
|
2007-08-06 |
2017-05-24 |
Biotie Therapies, Inc. |
Verfahren zur behandlung von sucht
|
|
AU2016208412A1
(en)
|
2007-08-06 |
2016-08-18 |
Biotie Therapies, Inc. |
Methods for treating dependence
|
|
FR2919861A1
(fr)
|
2007-08-06 |
2009-02-13 |
Sanofi Aventis Sa |
Le solvate d'isopranol de rimonabant, son procede de preparation et les compositions pharmaceutiques en contenant
|
|
CN101827828B
(zh)
|
2007-08-07 |
2013-02-27 |
普罗萨里克斯有限公司 |
作为5-羟色胺能调节剂的1,2,4-三唑衍生物
|
|
US8067028B2
(en)
|
2007-08-13 |
2011-11-29 |
Confluent Surgical Inc. |
Drug delivery device
|
|
US8318813B2
(en)
|
2007-09-13 |
2012-11-27 |
Lcs Group, Llc |
Method of treating binge eating disorder
|
|
JP5599712B2
(ja)
|
2007-10-05 |
2014-10-01 |
インターフェース バイオロジクス，インコーポレーテッド |
オリゴフッ素化架橋ポリマーおよびそれの使用
|
|
US20110053859A1
(en)
|
2007-10-10 |
2011-03-03 |
The U. S. Government Respresented by the Department of Veterans Affairs |
Methods to reduce the effects of sleep deprivation
|
|
WO2009055001A2
(en)
|
2007-10-23 |
2009-04-30 |
Fred Hutchinson Cancer Research Center |
Methods of treating aging and methods of screening candidate agents therefor
|
|
WO2009061436A1
(en)
|
2007-11-06 |
2009-05-14 |
University Of Florida Research Foundation |
Compound for activating 5-ht2c receptors in combination with an amphetamine compound
|
|
DE102007063210A1
(de)
|
2007-12-20 |
2009-06-25 |
Eberhard-Karls-Universität Tübingen Universitätsklinikum |
Arzneimittel zur Behandlung von Phantomphänomenen
|
|
WO2009079765A1
(en)
|
2007-12-21 |
2009-07-02 |
Cascade Therapeutics Inc. |
Compounds with activity at the 5-ht2c receptor
|
|
WO2009089234A2
(en)
|
2008-01-07 |
2009-07-16 |
Auspex Pharmaceuticals |
Substituted dibenzhydrylpiperazines
|
|
US8124126B2
(en)
|
2008-01-09 |
2012-02-28 |
Charleston Laboratories, Inc. |
Pharmaceutical compositions
|
|
WO2009091605A2
(en)
|
2008-01-17 |
2009-07-23 |
Health Innovations, Llc |
Taste titration therapies
|
|
US8329663B2
(en)
|
2008-01-31 |
2012-12-11 |
Paul Griffin |
Compositions and methods for the treatment of chronic infections
|
|
WO2009097596A1
(en)
|
2008-01-31 |
2009-08-06 |
Paul Griffin |
Compositions and methods for the treatment of chronic infections
|
|
RU2010136023A
(ru)
|
2008-02-01 |
2012-03-10 |
Асцендис Фарма Ас (Dk) |
Пролекарство, содержащее саморасщепляемый линкер
|
|
RU2540871C2
(ru)
|
2008-02-01 |
2015-02-10 |
Альфа-О Пептидес Аг |
Самоорганизующиеся пептидные наночастицы, полезные в качестве вакцин
|
|
US20090198145A1
(en)
|
2008-02-06 |
2009-08-06 |
Chow Harrison |
Compositions, methods, and systems for rapid induction and maintenance of continuous rem sleep
|
|
US20090318527A1
(en)
|
2008-02-11 |
2009-12-24 |
Howard Sard |
Indole compounds and methods of use thereof
|
|
US8859579B2
(en)
|
2008-03-21 |
2014-10-14 |
Richard Andrew Sewell |
Compostions and methods for preventing and/or treating disorders associated with cephalic pain
|
|
BRPI0910865A2
(pt)
|
2008-03-26 |
2017-05-30 |
Lonza Guangzhou Res And Dev Center Ltd |
processo para a síntese de etinilciclopropano
|
|
US20170276676A1
(en)
|
2008-03-27 |
2017-09-28 |
Gus J. Slotman |
System for assessing drug efficacy and response of a patient to therapy
|
|
WO2009118763A1
(en)
|
2008-03-28 |
2009-10-01 |
Panacea Biotec Limited |
Multilayered pharmaceutical compositions and processes thereof
|
|
US20090252786A1
(en)
|
2008-03-31 |
2009-10-08 |
Christoph Hanz |
Use of a Biologically Active Blood Serum for the Treatment of a Disorder Characterized in a Reduced Function of a GABA Receptor
|
|
EP2106799A1
(de)
|
2008-03-31 |
2009-10-07 |
OWEN Holding LTD |
Verwendung eines biologisch aktiven Blutserums zur Behandlung eines durch reduzierte Funktion eines GABA-Rezeptors vermittelten Leidens
|
|
FR2930147B1
(fr)
|
2008-04-18 |
2013-02-08 |
Flamel Tech Sa |
Forme orale solide dotee d'un double profil de liberation
|
|
EP2756756B1
(de)
|
2008-04-28 |
2016-01-06 |
Zogenix, Inc. |
Neuartige Formulierungen zur Behandlung von Migräne
|
|
US20110086063A1
(en)
|
2008-06-04 |
2011-04-14 |
Cornell University |
Vaccines for prevention and treatment of addiction
|
|
US10388179B2
(en)
|
2008-06-18 |
2019-08-20 |
Accenture Global Solutions Limited |
Analytics platform
|
|
EP2285362B1
(de)
|
2008-06-19 |
2017-08-09 |
LTS LOHMANN Therapie-Systeme AG |
Zusammensetzung zur transdermalen verabreichung kationischer wirkstoffe
|
|
EP2313037A1
(de)
|
2008-06-30 |
2011-04-27 |
Oron Zachar |
Dermale applikation von vasokonstriktoren
|
|
WO2010006249A1
(en)
|
2008-07-10 |
2010-01-14 |
Tyrx Pharma, Inc. |
Sustained release formulations of psychoactive drugs
|
|
US9642819B2
(en)
|
2008-07-10 |
2017-05-09 |
Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical |
Low dosage serotonin 5-HT2A receptor agonist to suppress inflammation
|
|
EP2331088A4
(de)
|
2008-08-06 |
2011-10-12 |
Gosforth Ct Holdings Pty Ltd |
Zusammensetzungen und verfahren zur behandlung von psychiatrischen erkrankungen
|
|
FR2935611B1
(fr)
|
2008-09-10 |
2010-10-15 |
Commissariat Energie Atomique |
Utilisation d'agents anti-connexines pour moduler l'effet therapeutique de molecules psychotropes
|
|
FR2936710B1
(fr)
|
2008-10-07 |
2011-01-07 |
Ceva Sante Animale |
Composition veterinaire antiprolactinique destinee aux ruminants
|
|
EP3006023B1
(de)
|
2009-01-20 |
2019-06-26 |
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center |
Sorbinsäure und derivate davon zur verstärkung der wirkung eines neuropharmakons
|
|
UA105657C2
(uk)
|
2009-02-27 |
2014-06-10 |
Хелсінн Терапьютікс (Ю.Ес.), Інк. |
Поліпшені способи лікування мігрені на основі анамореліну
|
|
WO2010124089A2
(en)
|
2009-04-22 |
2010-10-28 |
Synosia Therapeutics, Inc. |
Methods for treating dependence
|
|
US20120159656A1
(en)
|
2009-04-24 |
2012-06-21 |
Galenea Corp. |
Compositions and methods for evaluating cognitive defects
|
|
AU2010252740A1
(en)
|
2009-05-26 |
2012-01-12 |
Shire Llc |
Methods of enhancing selective serotonin reuptake inhibitor effects in mammals
|
|
GB201111485D0
(en)
|
2011-07-05 |
2011-08-17 |
Biocopea Ltd |
Drug composition and its use in therapy
|
|
US20110306596A1
(en)
|
2009-07-27 |
2011-12-15 |
Auspex Pharmaceuticals, Inc. |
Benzazepine inhibitors of gamma-secretase
|
|
WO2011020030A2
(en)
|
2009-08-13 |
2011-02-17 |
The General Hospital Corporation |
Methods and compositions to prevent addiction
|
|
US20110038915A1
(en)
|
2009-08-14 |
2011-02-17 |
Eduardo Jose Gonzalez |
Chewing Gum Formula for Enhancing Psycho-Spirituality
|
|
US20120171239A1
(en)
|
2009-09-03 |
2012-07-05 |
Mizel Steven B |
Immunogenic Conjugates for Producing Immune Responses to Drugs of Abuse and Methods of Use
|
|
WO2011027060A2
(fr)
|
2009-09-04 |
2011-03-10 |
Centre National De La Recherche Scientifique - Crns - |
Traitement par l'ocytocine de caracteristiques comportementales associees a l'autisme et a la timidite pathologique
|
|
CN102596278B
(zh)
|
2009-10-16 |
2016-06-29 |
帝斯曼知识产权资产管理有限公司 |
包含含有双-(α-氨基-二醇-二酯)的聚酯酰胺的涂层
|
|
FR2951378B1
(fr)
|
2009-10-16 |
2012-06-01 |
Flamel Tech Sa |
Forme pharmaceutique orale solide anti-mesusage et dotee d'un profil specifique de liberation modifiee
|
|
US20120321706A1
(en)
|
2009-10-19 |
2012-12-20 |
Intec Pharma Ltd. |
Novel gastroretentive dosage forms of poorly soluble drugs
|
|
CA3037168A1
(en)
|
2009-12-18 |
2011-06-23 |
Interface Biologics, Inc. |
Local delivery of drugs from self assembled coatings
|
|
LT2531200T
(lt)
|
2010-02-06 |
2017-09-25 |
Grünenthal GmbH |
Kristalizacijos būdas ir bioprieinamumas
|
|
CA2829180C
(en)
|
2010-03-05 |
2019-01-15 |
Newagriculture, Inc. |
Leaf protein-lipid-soluble material complexes
|
|
US20110217289A1
(en)
|
2010-03-05 |
2011-09-08 |
Basf Se |
Melt-Coated Dosage Forms
|
|
US9682133B2
(en)
|
2010-03-17 |
2017-06-20 |
Cornell University |
Disrupted adenovirus-based vaccine against drugs of abuse
|
|
WO2011138142A1
(en)
|
2010-05-07 |
2011-11-10 |
Ecole Polytechnique Federale De Lausanne (Epfl) |
Compositions and use of sulfasalazine
|
|
CA2792018A1
(en)
|
2010-05-10 |
2011-11-17 |
Segetis, Inc. |
Fragrant formulations, methods of manufacture thereof and articles comprising the same
|
|
US8765737B1
(en)
|
2010-05-11 |
2014-07-01 |
Demerx, Inc. |
Methods and compositions for preparing and purifying noribogaine
|
|
US8362007B1
(en)
|
2010-05-11 |
2013-01-29 |
Demerx, Inc. |
Substituted noribogaine
|
|
US20120108510A1
(en)
|
2010-05-20 |
2012-05-03 |
Emory University |
Methods of improving behavioral therapies
|
|
JP2012020991A
(ja)
|
2010-06-16 |
2012-02-02 |
Takasago Internatl Corp |
経皮吸収促進剤、及びこれを含有する皮膚外用製剤
|
|
US8802832B2
(en)
|
2010-06-22 |
2014-08-12 |
Demerx, Inc. |
Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier
|
|
MX2013000733A
(es)
|
2010-07-23 |
2013-05-30 |
Demerx Inc |
Composiciones de noribogaina.
|
|
US8900591B2
(en)
|
2010-08-20 |
2014-12-02 |
Heptares Therapeutics Limited |
Vaccines comprising mutant GPCRs with increased conformational stability relative to parent receptors
|
|
CA2812063A1
(en)
|
2010-08-30 |
2012-06-07 |
President And Fellows Of Harvard College |
Shear controlled release for stenotic lesions and thrombolytic therapies
|
|
WO2012031125A2
(en)
|
2010-09-01 |
2012-03-08 |
The General Hospital Corporation |
Reversal of general anesthesia by administration of methylphenidate, amphetamine, modafinil, amantadine, and/or caffeine
|
|
US20120129834A1
(en)
|
2010-09-17 |
2012-05-24 |
Buck Institute For Research On Aging |
Serotonin receptor antagonists for use in the treatment of huntington's disease
|
|
DK2618826T3
(en)
|
2010-09-20 |
2016-08-01 |
A Carlsson Res Ab |
Phenylpiperdine FOR TREATMENT OF DEMENTIA
|
|
EP2624821B1
(de)
|
2010-10-07 |
2018-06-27 |
Eaglepharma Pty Ltd |
Kombinationstherapie zur behandlung von depressionen und anderen nichtinfektiösen erkrankungen
|
|
WO2012054815A1
(en)
|
2010-10-22 |
2012-04-26 |
Duke University |
Slow-release formulations of 5-hydroxytryptophan as an adjunct to pro-serotonergic therapies
|
|
US20130230587A1
(en)
|
2010-11-10 |
2013-09-05 |
Rubicon Research Private Limited |
Sustained release compositions
|
|
WO2012066537A2
(en)
|
2010-11-15 |
2012-05-24 |
Neuroderm Ltd |
Compositions for transdermal delivery of active agents
|
|
CN103354902B
(zh)
|
2010-12-06 |
2016-03-02 |
特拉维夫大学拉玛特有限公司 |
药物检测方法和试剂盒
|
|
ES2842407T3
(es)
|
2010-12-22 |
2021-07-14 |
Syqe Medical Ltd |
Sistema de administración de fármacos
|
|
EP2481740B1
(de)
|
2011-01-26 |
2015-11-04 |
DemeRx, Inc. |
Verfahren und Zusammensetzungen zur Herstellung von Noribogain aus Voacangin
|
|
FR2971423B1
(fr)
|
2011-02-15 |
2014-01-10 |
Ceva Sante Animale |
Composition veterinaire antiprolactinique destinee aux ruminants
|
|
EP2691777A1
(de)
|
2011-03-28 |
2014-02-05 |
Flir Systems, Inc. |
Nachweis von analyten einschliesslich wirkstoffen
|
|
US8742096B2
(en)
|
2011-03-28 |
2014-06-03 |
Demerx, Inc. |
Methods and compositions for preparing noribogaine from voacangine
|
|
AR085840A1
(es)
|
2011-04-05 |
2013-10-30 |
Otsuka Pharma Co Ltd |
Medicamento que contiene un compuesto que es 7-[4-(4-benzo[b]tiofen-4-il-piperazin-1-il)butoxi]-1h-quinolin-2-ona
|
|
US20120282255A1
(en)
|
2011-04-07 |
2012-11-08 |
Greg Plucinski |
Methods and compositions for the treatment of alcoholism and alcohol dependence
|
|
KR20120128440A
(ko)
|
2011-05-17 |
2012-11-27 |
삼성전자주식회사 |
표적 물질 검출용 키트 및 이를 이용한 표적 물질 검출 방법
|
|
US20140163070A1
(en)
|
2012-05-17 |
2014-06-12 |
Bruce Roseman |
Treatment for cerebral palsy impaired speech in children
|
|
US9089563B2
(en)
|
2011-05-19 |
2015-07-28 |
Gilrose Pharmaceuticals, Llc |
Method of treating apraxia of speech in children
|
|
US8604035B2
(en)
|
2011-06-23 |
2013-12-10 |
Map Pharmaceuticals, Inc. |
Fluoroergoline analogs
|
|
AU2012308274B2
(en)
|
2011-09-15 |
2017-08-17 |
Demerx, Inc. |
Noribogaine salt ansolvates
|
|
WO2013061161A2
(en)
|
2011-10-28 |
2013-05-02 |
Green Bcn Consulting Services Sl |
New combination therapies for treating neurological disorders
|
|
US9493517B2
(en)
|
2011-11-07 |
2016-11-15 |
Glaxosmithkline Biologicals Sa |
Conjugates comprising an antigen and a carrier molecule
|
|
FR2983409B1
(fr)
|
2011-12-06 |
2013-12-27 |
Ethypharm Sa |
Comprime susceptible de lutter contre le detournement par voie injectable
|
|
CA3122767C
(en)
|
2011-12-08 |
2023-03-28 |
Demerx, Inc. |
Stereoselective total synthesis of noribogaine
|
|
EP2788356A4
(de)
|
2011-12-09 |
2015-10-21 |
Demerx Inc |
Sulfatester aus noribogain
|
|
WO2013085922A1
(en)
|
2011-12-09 |
2013-06-13 |
Demerx, Inc. |
Phosphate esters of noribogaine
|
|
EP2607352A1
(de)
|
2011-12-22 |
2013-06-26 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Pipecolat-Diketoamide zur Behandlung von psychatrischen Erkrankungen
|
|
EP2610245A1
(de)
|
2011-12-28 |
2013-07-03 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Pipecolat-Sulfonamide zur Behandlung psychischer Erkrankungen
|
|
WO2013112757A1
(en)
|
2012-01-25 |
2013-08-01 |
Demerx, Inc. |
Indole and benzofuran fused isoquinuclidene derivatives and processes for preparing them
|
|
WO2013112163A1
(en)
|
2012-01-25 |
2013-08-01 |
Demerx, Inc. |
Indole and benzofuran fused isoquinuclidene derivatives and processes for preparing them
|
|
WO2013112673A1
(en)
|
2012-01-25 |
2013-08-01 |
Demerx, Inc. |
Synthetic voacangine
|
|
EP2649989B1
(de)
|
2012-04-13 |
2017-10-18 |
King Saud University |
Verfahren zur Herstellung einer Feststoffdispersion, damit hergestellte Feststoffdispersion und Verwendung dafür
|
|
US20130295170A1
(en)
|
2012-05-03 |
2013-11-07 |
Kydes Pharmaceuticals Llc |
Compositions for control of drug abuse
|
|
JP2013233437A
(ja)
|
2012-05-07 |
2013-11-21 |
Otsuka Pharmaceut Co Ltd |
脳波振動のシグネチャ
|
|
CN108498532B
(zh)
|
2012-05-09 |
2021-07-23 |
坎泰克斯制药股份有限公司 |
骨髓抑制的治疗
|
|
US8784835B2
(en)
|
2012-07-02 |
2014-07-22 |
Trent Austin |
Method for producing muscimol and/or reducing ibotenic acid from amanita tissue
|
|
US20150196533A1
(en)
|
2012-07-02 |
2015-07-16 |
The General Hospital Corporation |
Method for concurrent treatment of pain and depression
|
|
EP2690102A1
(de)
|
2012-07-24 |
2014-01-29 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Bizyklische Aza-Amide zur Behandlung psychischer Erkrankungen
|
|
EA035868B1
(ru)
|
2012-08-17 |
2020-08-24 |
Смартек Интернэшнл Эл-Эл-Си |
Приготовление высушенных липосом для применения в системах выпуска в прессованном виде
|
|
CN107582544A
(zh)
|
2012-08-24 |
2018-01-16 |
英特格拉斯疗法有限公司 |
用于增强治疗剂透皮递送的化学组合物和方法
|
|
WO2014035473A1
(en)
|
2012-08-31 |
2014-03-06 |
Zoll Medical Corporation |
Cardiac resuscitation methods and kits
|
|
US20140100282A1
(en)
|
2012-10-10 |
2014-04-10 |
Patrick S L Wong |
Intranasal administration of pharmaceutical agents for treatment of neurological diseases
|
|
WO2014064703A1
(en)
|
2012-10-28 |
2014-05-01 |
Peritech Pharma Ltd. |
Pharmaceutical liquid adhesive compositions for treatment of anorectal disorders
|
|
US9670199B2
(en)
|
2012-11-19 |
2017-06-06 |
Regents Of The University Of Minnesota |
Ergoline derivatives as dopamine receptor modulators
|
|
WO2014093277A1
(en)
|
2012-12-11 |
2014-06-19 |
The Mclean Hospital Corporation |
Xenon and/or argon treatment as an adjunct to psychotherapy for psychiatric disorders
|
|
US9783535B2
(en)
|
2012-12-20 |
2017-10-10 |
Demerx, Inc. |
Substituted noribogaine
|
|
WO2014117089A1
(en)
|
2013-01-25 |
2014-07-31 |
Case Western Reserve University |
Compositions and methods for the treatment of pervasive development disorders
|
|
WO2014130581A1
(en)
|
2013-02-20 |
2014-08-28 |
Questcor Pharmaceuticals, Inc. |
Acth for treatment of migraine headache
|
|
AU2014229497A1
(en)
|
2013-03-10 |
2015-09-24 |
Peritech Pharma Ltd. |
Topical compositions and methods of treatment of topical disorders
|
|
US20140288454A1
(en)
|
2013-03-14 |
2014-09-25 |
Pulmonary Analytics |
Method For Using Exhaled Breath to Determine the Presence of Drug
|
|
US20160030408A1
(en)
|
2013-03-15 |
2016-02-04 |
Bhl Patent Holdings Llc |
Materials and methods for treating neuropathies and related disorders including those involving a keystone nerve
|
|
WO2014142938A1
(en)
|
2013-03-15 |
2014-09-18 |
Aihol Corporation |
Pharmaceutical formulation containing glycosaminoglycan
|
|
CN105209445B
(zh)
|
2013-03-15 |
2018-01-23 |
梅利奥尔制药Ii有限责任公司 |
治疗运动障碍和相关病症的方法
|
|
WO2014143201A1
(en)
|
2013-03-15 |
2014-09-18 |
Demerx, Inc. |
Method for noribogaine treatment of addiction in patients on methadone
|
|
WO2014176556A1
(en)
|
2013-04-26 |
2014-10-30 |
Express Diagnostics International, Inc. |
Portable testing system for detecting selected drugs or compounds in non-controlled environments
|
|
WO2014186623A2
(en)
|
2013-05-17 |
2014-11-20 |
Biomed Valley Discoveries |
Methods and compositions for the treatment of a chagas disease
|
|
US9737490B2
(en)
|
2013-05-29 |
2017-08-22 |
Grünenthal GmbH |
Tamper resistant dosage form with bimodal release profile
|
|
CA2817728A1
(en)
|
2013-05-31 |
2014-11-30 |
Pharmascience Inc. |
Abuse deterrent immediate release formulation
|
|
MX2015016675A
(es)
|
2013-06-04 |
2016-07-15 |
Vyome Biosciences Pvt Ltd |
Particulas recubiertas y composiciones que comprenden las mismas.
|
|
US20140364367A1
(en)
|
2013-06-08 |
2014-12-11 |
Sedogen, Llc |
Methods of treating prader willi syndrome and conditions associated with low basal metabolic rate or hyperphagia using a katp channel opener
|
|
EP2818177A1
(de)
|
2013-06-24 |
2014-12-31 |
Celica, D.O.O. |
Mechanismus und Arzneimittelziele zur Senkung des Zellödems (Nervenschutz) und zytoplasmische Erregbarkeit in Astrozyten in normalen und pathologischen Zuständen
|
|
AU2014284333B2
(en)
|
2013-07-03 |
2017-03-16 |
Acura Pharmaceuticals, Inc. |
Methods and compositions for deterring abuse
|
|
PE20160556A1
(es)
|
2013-07-08 |
2016-06-11 |
Auspex Pharmaceuticals Inc |
Compuestos neurotransmisores de dihidroxifenilo, composiciones y metodos
|
|
CN105682643B
(zh)
|
2013-07-12 |
2019-12-13 |
格吕伦塔尔有限公司 |
含有乙烯-醋酸乙烯酯聚合物的防篡改剂型
|
|
US9770514B2
(en)
|
2013-09-03 |
2017-09-26 |
ExxPharma Therapeutics LLC |
Tamper-resistant pharmaceutical dosage forms
|
|
US10098893B2
(en)
|
2013-10-03 |
2018-10-16 |
Northwestern University |
Methods of administering a trace amine-associated receptor 1 (TAAR1) agonist to patients having the minor allele of the single nucleotide polymorphism rs2237457
|
|
US9474481B2
(en)
|
2013-10-22 |
2016-10-25 |
Mindstrong, LLC |
Method and system for assessment of cognitive function based on electronic device usage
|
|
US9420970B2
(en)
|
2013-10-22 |
2016-08-23 |
Mindstrong, LLC |
Method and system for assessment of cognitive function based on mobile device usage
|
|
CA2927738A1
(en)
|
2013-10-31 |
2015-05-07 |
Cima Labs Inc. |
Abuse-deterrent dosage forms
|
|
WO2015065547A1
(en)
|
2013-10-31 |
2015-05-07 |
Cima Labs Inc. |
Immediate release abuse-deterrent granulated dosage forms
|
|
TW201605856A
(zh)
|
2013-11-01 |
2016-02-16 |
艾尼納製藥公司 |
５－ＨＴｃ受體促效劑
|
|
WO2015066344A1
(en)
|
2013-11-01 |
2015-05-07 |
Arena Pharmaceuticals, Inc. |
5-ht2c receptor agonists and compositions and methods of use
|
|
CN103549133A
(zh)
|
2013-11-05 |
2014-02-05 |
杨剑 |
有机猪牧草饲料
|
|
CN103535561A
(zh)
|
2013-11-05 |
2014-01-29 |
杨剑 |
饲养大猪用的牧草饲料
|
|
CN103751943B
(zh)
|
2014-01-13 |
2020-10-13 |
湖北及安盾消防科技有限公司 |
一种含有含氮类有机化合物的灭火组合物
|
|
AU2014379612A1
(en)
|
2014-01-24 |
2016-08-11 |
Demerx, Inc. |
Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier
|
|
CN103773056B
(zh)
|
2014-01-24 |
2015-11-18 |
山东大学 |
高脆性透明类岩石材料试件制备方法
|
|
CA3212001A1
(en)
|
2014-03-03 |
2015-09-11 |
Demerx, Inc. |
Therapeutic uses of ibogaine and related compounds
|
|
US20150258114A1
(en)
|
2014-03-13 |
2015-09-17 |
Demerx, Inc. |
Methods for acute and long-term treatment of substance abuse using ibogaine
|
|
EP3151906B1
(de)
|
2014-06-03 |
2019-12-11 |
Pop Test Abuse Deterrent Technology LLC |
Zur drahtlosen kommunikation konfigurierte arzneimittelvorrichtung
|
|
KR20170031251A
(ko)
|
2014-07-30 |
2017-03-20 |
클리브랜드 바이오랩스, 아이엔씨. |
플라젤린 조성물 및 용도
|
|
US10231651B2
(en)
|
2014-09-25 |
2019-03-19 |
Bae Systems Information And Electronic Systems Integration Inc. |
Gait authentication system and method thereof
|
|
US10058253B2
(en)
|
2014-11-11 |
2018-08-28 |
Zenmark, Llc |
System, method, and article for heart rate variability monitoring
|
|
WO2016145193A1
(en)
|
2015-03-10 |
2016-09-15 |
Eleusis Benefit Corporation, Pbc |
Lsd for the treatment of alzheimer's disease
|
|
JP6910947B2
(ja)
|
2015-03-24 |
2021-07-28 |
協和キリン株式会社 |
核酸含有脂質ナノ粒子
|
|
US10254298B1
(en)
|
2015-03-25 |
2019-04-09 |
National Technology & Engineering Solutions Of Sandia, Llc |
Detection of metabolites for controlled substances
|
|
WO2016161138A1
(en)
*
|
2015-03-31 |
2016-10-06 |
Stamets Paul Edward |
Antiviral activity from medicinal mushrooms and their active constituents
|
|
BR112017023088B1
(pt)
|
2015-04-27 |
2023-10-03 |
Arena Pharmaceuticals, Inc |
Compostos agonistas do receptor 5-ht2c, composição farmacêutica,seu processo de preparação e seus usos
|
|
CN107073293A
(zh)
|
2015-05-01 |
2017-08-18 |
托匹泰克以色列制药有限公司 |
用于治疗鼻出血的组合物
|
|
US20180147142A1
(en)
|
2015-05-19 |
2018-05-31 |
Joseph Robert Knight |
Method for isolation of alkaloids and amino acids, and compositions containing isolated alkaloids and amino acids
|
|
WO2016187277A1
(en)
|
2015-05-19 |
2016-11-24 |
Joseph Robert Knight |
Method for isolation of alkaloids and amino acids, and compositions containing isolated alkaloids and amino acids
|
|
US9737759B2
(en)
|
2015-07-17 |
2017-08-22 |
Genesant Technologies, Inc. |
Automatic application-based exercise tracking system and method
|
|
US10272094B2
(en)
|
2015-07-31 |
2019-04-30 |
Arena Pharmaceuticals, Inc. |
5-HT2C receptor agonists and compositions and methods of use
|
|
US9614734B1
(en)
|
2015-09-10 |
2017-04-04 |
Pearson Education, Inc. |
Mobile device session analyzer
|
|
US20180021326A1
(en)
|
2016-07-23 |
2018-01-25 |
Paul Edward Stamets |
Compositions and methods for enhancing neuroregeneration and cognition by combining mushroom extracts containing active ingredients psilocin or psilocybin with erinacines or hericenones enhanced with niacin
|
|
EA038219B1
(ru)
|
2016-08-19 |
2021-07-26 |
Арена Фармасьютикалз, Инк. |
Агонисты рецептора 5-ht2c и композиции, а также способ их применения
|
|
US10596378B2
(en)
|
2016-10-18 |
2020-03-24 |
Joseph Rustick |
Method for treatment of depression using synaptic pathway training
|
|
US20180195455A1
(en)
|
2017-01-12 |
2018-07-12 |
GM Global Technology Operations LLC |
Engine combustion phasing control during transient state
|
|
NL2018190B1
(en)
*
|
2017-01-18 |
2018-07-26 |
Procare Beheer B V |
Psilocybin or psilocin in combination with cannabinoid
|
|
AU2018216185B2
(en)
|
2017-02-02 |
2023-08-03 |
Mcmaster University |
Bicarbonate as a potentiator for antimicrobial agents
|
|
WO2018145219A1
(es)
|
2017-02-09 |
2018-08-16 |
Serani Mostazal Jorge |
Composición farmaceutica para la prevención y tratamiento de las adicciones a traves de un contracondicionamiento aversivo
|
|
US10933073B2
(en)
|
2017-02-09 |
2021-03-02 |
Caamtech Llc |
Compositions and methods comprising a psilocybin derivative
|
|
US20190142851A1
(en)
|
2017-11-16 |
2019-05-16 |
CaaMTech, LLC |
Compositions comprising a psilocybin derivative and a cannabinoid
|
|
CN108619214A
(zh)
|
2017-03-15 |
2018-10-09 |
王慎君 |
一种治疗肿瘤的药物
|
|
GB2577810A
(en)
|
2017-03-30 |
2020-04-08 |
Ojai Energetics Pbc |
Methods and compositions for enhancing health
|
|
CN111212837A
(zh)
|
2017-04-07 |
2020-05-29 |
艾森医药公司 |
吡咯并嘧啶激酶抑制剂的药用盐、物理形态和组合物及其制备方法
|
|
WO2018195455A1
(en)
|
2017-04-20 |
2018-10-25 |
Eleusis Benefit Corporation, Pbc |
Assessing and treating psychedelic-responsive subjects
|
|
US20180343812A1
(en)
|
2017-05-31 |
2018-12-06 |
Insectergy, Llc |
Cannabis farming systems and methods
|
|
US20190246591A1
(en)
|
2017-05-31 |
2019-08-15 |
Insectergy, Llc |
Insect and cannabis production systems and methods
|
|
JP2020522693A
(ja)
|
2017-06-02 |
2020-07-30 |
ノースウェスタン ユニヴァーシティＮｏｒｔｈｗｅｓｔｅｒｎ Ｕｎｉｖｅｒｓｉｔｙ |
汗の中の注目する標的の検出および分析のための薄い軟質皮膚装着マイクロ流体ネットワーク
|
|
CN107252080A
(zh)
|
2017-07-12 |
2017-10-17 |
沈建国 |
一种麻菇酱油的配方
|
|
GB2571696B
(en)
|
2017-10-09 |
2020-05-27 |
Compass Pathways Ltd |
Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced
|
|
EP3698260A4
(de)
|
2017-10-19 |
2021-08-04 |
Eleusis Health Solutions US, Inc. |
Verfahren und systeme zur erhöhung der sicherheit von bewusstseinserweiternden arzneimitteltherapien
|
|
WO2019081764A1
(en)
|
2017-10-26 |
2019-05-02 |
Consejo Superior De Investigaciones Científicas (Csic) |
ASSOCIATION PRODUCT FOR THE TREATMENT OF NEUROLOGICAL AND / OR PSYCHIATRIC DISORDERS
|
|
US10703325B2
(en)
|
2017-11-27 |
2020-07-07 |
Autoliv Asp, Inc. |
Multi-chambered side airbag assemblies
|
|
AU2018381331A1
(en)
|
2017-12-04 |
2020-07-23 |
Victoria Cogger |
Compositions and methods for modulating liver endothelial cell fenestrations
|
|
FI128750B
(en)
|
2017-12-21 |
2020-11-30 |
Helsingin Yliopisto |
Methods for determining the therapeutic effect of fast-acting antidepressants and related individual antidepressant therapy
|
|
US20190224277A1
(en)
|
2018-01-22 |
2019-07-25 |
CyPhi LLC |
Bio-mimetic formulation
|
|
WO2019161050A1
(en)
|
2018-02-18 |
2019-08-22 |
Akili Interactive Labs, Inc. |
Cognitive platform including computerized elements coupled with a therapy for mood disorder
|
|
CN112105734A
(zh)
|
2018-03-08 |
2020-12-18 |
新图集生物技术有限责任公司 |
生产色胺的方法
|
|
FI129102B
(en)
|
2018-03-19 |
2021-07-15 |
Teknologian Tutkimuskeskus Vtt Oy |
Heterological production of psilosybin
|
|
US11426367B2
(en)
|
2018-05-04 |
2022-08-30 |
Perception Neuroscience, Inc. |
Methods of treating substance abuse
|
|
US12083116B2
(en)
|
2018-06-21 |
2024-09-10 |
Robert John Petcavich |
Method of inducing dendritic and synaptic genesis in neurodegenerative chronic diseases
|
|
WO2020024060A1
(en)
|
2018-08-01 |
2020-02-06 |
Mcmaster University |
Methods for inhibiting microbe growth
|
|
US12090145B2
(en)
|
2018-08-20 |
2024-09-17 |
Yale University |
Combination therapy for treating or preventing depression or other mood diseases
|
|
WO2020053196A1
(en)
|
2018-09-10 |
2020-03-19 |
Universität Basel |
Method for the biocatalytic alkylation of a substrate
|
|
US10974020B2
(en)
|
2019-01-04 |
2021-04-13 |
Apollo Neuroscience, Inc. |
Systems and methods of mitigating negative effects of therapies with transcutaneous vibration
|
|
EP3917537A4
(de)
|
2019-01-30 |
2022-09-07 |
Diamond Therapeutics Inc. |
Verfahren und zusammensetzungen mit einem 5ht-rezeptoragonisten zur behandlung von psychischen, kognitiven, verhaltens- und/oder gemütsstörungen
|
|
KR20220009954A
(ko)
|
2019-04-17 |
2022-01-25 |
컴퍼스 패쓰파인더 리미티드 |
신경인지 장애, 만성 통증을 치료하고 염증을 감소시키는 방법
|
|
US11766445B2
(en)
|
2019-07-18 |
2023-09-26 |
Concept Matrix Solutions |
Oral soft gel capsule containing psychedelic compound
|
|
EP4009026B1
(de)
|
2020-12-02 |
2024-09-18 |
Volvo Truck Corporation |
Ein luftbetriebenes fahrzeugsystem und ein verfahren zum erkennen von leckagen in einem luftbetriebenen fahrzeugsystem
|
|
TW202304466A
(zh)
|
2021-03-30 |
2023-02-01 |
英商康派斯開拓者公司 |
賽洛西賓（ｐｓｉｌｏｃｙｂｉｎ）組成物，其製備方法及使用方法
|